Loading your page…

Marketing-authorisation holder · Germany

InfectoPharm Arzneimittel und Consilium GmbH

Germany30 medicines4 countries

30 medicines in 4 countries, as authorisation holder, manufacturer and marketer.

Its medicines

Group structure

Part of

InfectoPharmPharmaceutical group

Other companies in the group

Headquarters not stated1

INFECTOPHARM ARZ.UND CONS.GmbH

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

1–25 of 30

Medicine	Substance	Country	Status	Authorised
BACNAS 20 MG/G POMADA NASAL21,5 mg · Pomada nasal	Mupirocin	Spain	Marketed	2020
CEXIDALGocce auricolari, soluzione	Ciprofloxacin, Fluocinolone acetonide	Italy	Authorised
CILODEXGocce auricolari, sospensione	Desametasone	Italy	Authorised
CLOTICGocce auricolari, soluzione	Clotrimazole	Italy	Authorised
DOLOLIBRESospensione orale	Naproxen	Italy	Authorised
DOLOTOGocce auricolari, soluzione	Phenazone, Procaine	Italy	Authorised
EKZEMGocce auricolari, soluzione	Fluocinolone acetonide	Italy	Authorised
Fomicyt 40 mg/ml poeder voor oplossing voor infusiePoeder voor oplossing voor infusie	Fosfomycin	Netherlands	Authorised	2015
Fomicyt 40 mg/ml prašak za otopinu za infuzijuprašak za otopinu za infuziju	Fosfomycin	Croatia	Marketed	2020
INFECTOFOSSoluzione per infusione	Fosfomycin	Italy	Authorised
INFECTOSCABCrema	Permethrin	Italy	Authorised
MUPIDERUnguento	Mupirocin	Italy	Authorised
MUPIDER NASALEUnguento nasale	Mupirocin	Italy	Authorised
Mupirocine InfectoPharm, 20 mg/g, neuszalfNeuszalf	Mupirocin	Netherlands	Authorised	2019
NAPROXENO INFECTOPHARM 50 MG/ML SUSPENSION ORAL50 mg/ml · Suspensión oral	Naproxen	Spain	Authorised	2021
NASIPRALSpray nasale, soluzione	Ipratropium bromide	Italy	Authorised
NASIPRAL 0,3 MG/ML SOLUCION PARA PULVERIZACION NASAL0,313 mg/ml · Solucion para pulverizacion nasal	Ipratropium bromide	Spain	Authorised	2026
Permetrine InfectoPharm, 50 mg/g, crèmeCrème	Permethrin	Netherlands	Authorised	2022
RITALINCompressa	Methylphenidate	Italy	Authorised
RITALIN EFFETTO PROLUNGATOCapsula rigida a rilascio modificato	Methylphenidate	Italy	Authorised
Ritalin LA 10 mg, harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard	Methylphenidate	Netherlands	Authorised	2016
Ritalin LA 20 mg, harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard	Methylphenidate	Netherlands	Authorised	2016
Ritalin LA 30 mg, harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard	Methylphenidate	Netherlands	Authorised	2016
Ritalin LA 40 mg, harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard	Methylphenidate	Netherlands	Authorised	2016
Ritalin LA 60 mg, harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard	Methylphenidate	Netherlands	Authorised	2016

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Italy	15	15	0	Companies All medicines
Netherlands	10	10	0	Companies All medicines
Spain	4	3	1	Companies All medicines
Croatia	1	1	0	Companies All medicines

Also in the registers of France, Serbia, United Kingdom

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

All 10 sources

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl)

Report an error or request removalCorrections from the company itself are welcome.

InfectoPharm Arzneimittel und Consilium GmbH

Group structure

Part of

Other companies in the group

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Germany: more companies